Mirum Pharmaceuticals, Inc.

United States of America


 
Total IP 79
Total IP Rank # 17,105
IP Activity Score 2.8/5.0    76
IP Activity Rank # 9,347
Stock Symbol
ISIN US6047491013
Market Cap. 2,100M  (USD)
Industry Biotechnology
Sector Healthcare
Dominant Nice Class Pharmaceutical, veterinary and s...

Patents

Trademarks

16 20
8 14
10 7
4
 
Last Patent 2025 - Pharmaceutical compositions comp...
First Patent 2020 - Methods for increasing growth in...
Last Trademark 2025 - MIRUM EMBRACE PATIENT SUPPORT PR...
First Trademark 2009 - CHENODAL

Industry (Nice Classification)

Latest Inventions, Goods, Services

2025 G/S Provision of information and materials on pharmaceutical treatments, disease awareness, treatment...
2024 G/S Providing medical and scientific research information in the field of pharmaceuticals and clinica...
G/S Pharmaceutical preparations for the treatment of metabolic disorders; pharmaceutical preparations...
Invention Pharmaceutical compositions comprising 2,3,4,5-tetrahydro-benzothiepin-1,1-dioxide derivatives an...
Invention Pharmaceutical compositions comprising 2,3,4,5- tetrahydrobenzothiepin- 1,1-dioxide derivatives a...
G/S Pharmaceutical preparations for the treatment of bile acid metabolic disorders; pharmaceutical pr...
G/S Genetic testing kits, namely, genetic identity tests comprised of reagents for medical purposes. ...
G/S Genetic testing kits comprised of medical specimen collection devices in the nature of glass tube...
G/S Genetic testing kits. Printed publications featuring information relating to genetic testing kits...
Invention Methods for treating cholestasis. Provided herein are methods for treating cholestasis in a subj...
2023 Invention Methods for treating progressive familial intrahepatic cholestasis. Provided herein are methods ...
Invention Methods for treating progressive familial intrahepatic cholestasis. Provided herein are methods f...
Invention Methods for treating progressive familial intrahepatic cholestasis
Invention Pharmaceutical compositions comprising maralixibat and uses thereof. The invention relates to a p...
Invention Maralixibat solid forms, intermediates and processes of making same. The present invention relat...
Invention Maralixibat solid forms, intermediates and processes of making same. The present invention relate...
2022 Invention Treatment with ileal bile acid transporter (ibat) inhibitors for increased event-free survival (e...
Invention Apical sodium-dependent transporter inhibitor compositions. Provided herein are pharmaceutical c...
Invention Methods of dosing of apical sodium-dependent bile acid transporter inhibitors (asbtis). The prese...
Invention Apical sodium-dependent transporter inhibitor compositions. Provided herein are pharmaceutical co...
Invention Methods of dosing of apical sodium-dependent bile acid transporter inhibitors (asbtis). The pres...
Invention Methods for treating cholestasis. Provided herein are methods for treating cholestasis in a subje...
2021 G/S Providing patient resource services, namely, information about liver diseases and disorders in th...
G/S Providing patient resource services in the form of symptom tracking via printed materials and a ...
G/S Pharmaceutical preparations for the treatment of rare liver diseases and disorders; pharmaceutica...
G/S Pharmaceutical preparations.
G/S Pharmaceutical preparations for the treatment of liver disease.
G/S Pharmaceutical preparations for the treatment of liver disease.
G/S Downloadable mobile application featuring technology that enables users to enter, access, track, ...
G/S Pharmaceutical preparations for the treatment of liver disease
G/S Charitable services, namely, patient assistance program to provide drugs free of charge to low-in...
2020 G/S Genetic testing for medical purposes; providing information in the field of screening, diagnosis ...
Invention Methods for increasing growth in pediatric subjects having cholestatic liver disease. Provided h...
Invention Genotype and dose-dependent response to an asbti in patients with bile salt export pump deficienc...
Invention Methods for increasing growth in pediatric subjects having cholestatic liver disease. Provided he...
2019 G/S Pharmaceutical preparations for the treatment of liver diseases and conditions.
G/S Pharmaceutical preparations for the treatment of liver diseases and conditions
G/S Medical health assessment instrument in the nature of a printed evaluation and diagnostic questio...
2015 G/S Pharmaceutical preparations for use in treatment of individuals with primary and secondary defect...
G/S Pharmaceutical preparations for use in treatment of individuals with primary and secondary defec...
G/S Providing medical information, consultancy and advisory services; providing medical information r...
2013 G/S Computer application software for mobile devices, namely, software for providing printed patient-...
2011 G/S Pharmaceutical preparations containing chenodiol or derivatives thereof in oral dosage form for t...